期刊文献+

肝细胞癌组织中环氧化酶2与增殖性细胞核抗原的表达及相关性

Expression and correlation of cyclooxygenese-2 and proliferating cell nuclear antigen in hepatocellular carcinoma
原文传递
导出
摘要 目的观察环氧化酶2(COX-2)和增殖性细胞核抗原(PCNA)在肝细胞癌组织中的表达及相关性。方法应用免疫组化法检测肝细胞癌组织COX-2与PCNA蛋白的表达,并对阳性结果进行图像分析。结果肝癌组织和癌旁组织中COX-2、PCNA阳性表达率及其阳性面积百分比差异均有统计学意义(P<0.05)。COX-2阳性组和COX-2阴性组中PCNA阳性表达率之间差异有统计学意义(P<0.05)。肝癌组织和癌旁组织中COX-2阳性表达面积百分比与PCNA阳性表达面积百分比之间有相关性。结论肝细胞癌组织存在COX-2过度表达,且与PCNA表达水平有相关性。 Objective To study the expression of cyclooxygenase-2(COX-2)and proliferating cell nuclear antigen(PCNA)in hepatocellular carcinoma(HCC)and their relationship.MethodsExpressions of COX-2 and PCNA were detected with immunohistochemistry assay and the results were analyzed by computer-aided image analysis system.Results The positive expression rate and percentage of area of COX-2 and PCNA were significantly different between HCC and tumor-adjacent tissures(P〈0.05).The positive expression rate was significantly different between COX-2-positive and COX-2-negative tissures(P〈0.05).The percentage of positive expression area was significantly different between HCC and tumor-adjacent tissures(P〈0.05).Conclusion COX-2 is overexpressed in HCC,which is correlated with the expression level of PCNA.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第7期745-746,共2页 Jiangsu Medical Journal
基金 国家自然科学基金(30470784)
关键词 肝细胞癌 环氧化酶2 增殖性细胞核抗原 Hepatocellular carcinoma Cyclooxygenase-2 Proliferating cell nuclear antigen
  • 相关文献

参考文献7

二级参考文献46

  • 1Gao-Song Wu,Ju-Hua Wang,Zheng-Ren Liu,Sheng-Quan Zou the Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2002,1(3):429-433. 被引量:15
  • 2Melchiorre Cervello,Giuseppe Montalto.Cyclooxygenases in hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(32):5113-5121. 被引量:25
  • 3Ji Yeon Baek,Wonhee Hur,Jin Sang Wang,Si Hyun Bae,Seung Kew Yoon.Selective COX-2 inhibitor,NS-398,suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest[J].World Journal of Gastroenterology,2007,13(8):1175-1181. 被引量:27
  • 4[1]Doubilet P, Donowitz M, Pauker SG. Evaluation for colon cancer in patients with occult fecal blood loss while taking aspirin: a Bayesian viewpoint. Med Decis Making, 1982, 2(2):147~160.
  • 5[2]Smalley W, Ray WA, Daugherty J, et al. Use of nonsteroidal anti- inflammatory drugs and incidence of colorectal cancer.Arch Intern Med, 1999, 159(2): 161~166.
  • 6[3]Thun M J, Calle E E, Namboodiri MM, et al. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst, 1992, 84(19): 1491~1500.
  • 7[4]Gustafson- svard C, Lilja I, Hallbook O, et al. Yclooxygenase- 1 and cyclooxygenase- 2 gene expression in human colorectaladenocarcinomas and in azoxymethane induced colonic tumouts in rats. Gut, 1996, 38: 79~84.
  • 8[5]Elder DJE, Hague A, Hicks DJ, et al. Differential growth inhibition by the aspirin metabotite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitrotransformed adenoma relative to adenoma cell lines. Cancer Res, 1996, 56(3): 2273~2276.
  • 9[6]Sheng H, Shao J, Morrow JD, et al. Modulation of apoptosis and Bcl - 2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res, 1998, 58(1): 362~366.
  • 10[7]Sano H, Kawahito Y, Wild RL, et al. Expression of cyclooxygenase- 1 and - 2 in human colorectal cancer. Cancer Res,1995, 55(9): 3785~3789.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部